{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:01:49Z","timestamp":1760781709591},"reference-count":23,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ejphar.2012.05.014","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T09:01:39Z","timestamp":1338454899000},"page":"132-138","source":"Crossref","is-referenced-by-count":6,"title":["K-134, a phosphodiesterase 3 inhibitor, improves gait disturbance and hindlimb blood flow impairment in rat peripheral artery disease models"],"prefix":"10.1016","volume":"689","author":[{"given":"Yusuke","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohei","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.05.014_bib1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2012.05.014_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jvs.2011.09.004","article-title":"A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication","volume":"55","author":"Brass","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ejphar.2012.05.014_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2012.05.014_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00878514","article-title":"Effect of propionyl-l-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study","volume":"7","author":"Corsico","year":"1993","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2012.05.014_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2012.05.014_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2012.05.014_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/CIA.S1735","article-title":"Management of peripheral arterial disease in the elderly: focus on cilostazol","volume":"3","author":"Falconer","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejphar.2012.05.014_bib9","first-page":"917","article-title":"A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats","volume":"12","author":"Goto","year":"1986","journal-title":"Drugs. Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2012.05.014_bib10","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication","volume":"344","author":"Hiatt","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2012.05.014_bib11","doi-asserted-by":"crossref","first-page":"H2012","DOI":"10.1152\/ajpheart.00257.2002","article-title":"Collateral arteries grow from preexisting anastomoses in the rat hindlimb","volume":"283","author":"Herzog","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.05.014_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.lfs.2007.07.025","article-title":"NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model","volume":"81","author":"Ishiwata","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2012.05.014_bib13","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0960-894X(98)00246-7","article-title":"2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities","volume":"8","author":"Koga","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2012.05.014_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2005.11.027","article-title":"Intermittent claudication","volume":"187","author":"Meru","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2012.05.014_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0741-5214(98)70357-X","article-title":"Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease","volume":"27","author":"Money","year":"1998","journal-title":"J. Vasc. Surg."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2012.05.014_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.ejphar.2012.05.014_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2009.03.073","article-title":"Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseases","volume":"612","author":"Ogawa","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.014_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vascn.2003.08.001","article-title":"A method for evaluating drug effects on intermittent claudication using a treadmill in rats with unilateral hindlimb artery occlusion","volume":"49","author":"Orito","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2012.05.014_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-2952(99)00346-9","article-title":"Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity","volume":"59","author":"Sudo","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.014_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2006.02.048","article-title":"Effect of YM-254890, a specific Galphaq\/11 inhibitor, on experimental peripheral arterial disease in rats","volume":"536","author":"Uemura","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.05.014_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0049-3848(95)00169-R","article-title":"Anti-platelet effects of clopidogrel in rat middle cerebral artery thrombosis model","volume":"80","author":"Umemura","year":"1995","journal-title":"Thrombosis Res."},{"key":"10.1016\/j.ejphar.2012.05.014_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccl.2011.04.003","article-title":"Medical management of the patient with intermittent claudication","volume":"29","author":"Vodnala","year":"2011","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.ejphar.2012.05.014_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1160\/TH10-07-0439","article-title":"Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation","volume":"105","author":"Yoshida","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2012.05.014_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2011.12.044","article-title":"A phosphodiesterase 3 inhibitor, K-134, improves hindlimb skeletal muscle circulation in rat models of peripheral arterial disease","volume":"221","author":"Yoshida","year":"2012","journal-title":"Atherosclerosis"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912004414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912004414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T03:26:45Z","timestamp":1542943605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912004414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":23,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0014299912004414"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.05.014","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}